Nasdaq
$5.51▼ 0.90%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $200.2MShares out 36.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
22- 2d agoAfter-hours26.10.23 05:458-KKey event#●●●
Profound Medical Corp.
Profound Medical announced that television host Montel Williams will join its upcoming 'Let's Huddle' webinar on November 5, 2026. This patient advocacy initiative aims to provide education, connection, and support to men and their families navigating the prostate care journey.…more
$5.51-0.90%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.14Pre-market26.10.14 21:008-KKey event
Profound Medical Corp.
Profound Medical announced five abstracts at the 15th Interventional MRI Symposium, reinforcing the clinical efficacy and platform expansion potential of its TULSA-PRO system. Key findings include superior functional preservation compared to robotic radical prostatectomy in the CAPTAIN trial and successful technical validation on the Siemens 0.55T MRI platform to reduce infrastructure barriers.…more
$5.51-0.90%vs prev closeView filingShare - 10.9Regular26.10.10 02:118-KKey event
Profound Medical Corp.
Profound Medical has entered into a co-education agreement with Telix Pharmaceuticals to advance PSMA-informed prostate cancer care. The collaboration aims to educate physicians on the complementary roles of Telix's PSMA-PET imaging technologies and Profound's TULSA-PRO MRI-guided ablation platform to optimize patient treatment plans.…more
$5.51-0.90%vs prev closeView filingShare
21 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoAfter-hours26.10.23 05:15#●●●
Profound Medical to Host Webinar Featuring TV Host Montel Williams
Profound Medical announced that television host Montel Williams will join its 'Let’s Huddle' webinar to discuss patient advocacy and prostate care. This initiative is part of the company's patient education efforts and does not represent a direct financial or commercial development.…more
$5.51-0.90%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.14Pre-market26.10.14 20:30
●●●●●●●● ●●●●● ●●●●●●
Profound Medical presented clinical data at the iMRI Symposium demonstrating the efficacy and potential platform expansion of its TULSA-PRO system. These findings serve as academic validation rather than immediate commercial or regulatory milestones.…more
$5.51-0.90%vs prev close - 10.9Pre-market26.10.09 20:45
●●●●●●●● ●●●●● ●●●●●●
Profound Medical has entered into a co-education agreement with Telix Pharmaceuticals to integrate advanced molecular imaging with MRI-guided therapy. The collaboration aims to improve patient selection and treatment planning for prostate cancer through physician education and technology integration.…more
$5.51-0.90%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report